• 1
    Bennett LE, Keck BM, Daily OP et al. Worldwide thoracic organ transplantation: a report from the. UNOS/ISHLT international registry for thoracic organ transplantation. Clin Transplant 2000; 3144.
  • 2
    Reinsmoen NL, Bolman RM, Savik K et al. Are multiple immunopathogenic events occurring during the development of obliterative bronchiolitis and acute rejection? Transplantation 1993; 55: 10401044.
  • 3
    Hammond EH, Yowell RL, Nunoda S et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 1989; 8: 430443.
  • 4
    Lones MA, Czer LS, Trento A et al. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. J Heart Lung Transplant 1995; 14: 151162.
  • 5
    Mauiyyedi S, Crespo M, Collins AB et al. Acute humoral rejection in kidney transplantation. II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779787.
  • 6
    Sconik JC, Zander DS, Baz MA et al. Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry. Transplantation., 1999; 68: 15421546.
  • 7
    Magro CM, Deng A, Pope-Harman A et al. Humorally mediated post transplant septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation 2002; 74: 12731280.
  • 8
    Bohmig GA, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 10911099.
  • 9
    Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 22082214.
  • 10
    Nickeleit V, Zeiler M, Gudat F et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242251.
  • 11
    Bohmig GA, Regele H, Exner M et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 2001; 12 (11): 24822489.
  • 12
    Bohmig GA, Exner M, Watschinger B et al. C4d deposits in renal allografts are associated with inferior graft outcome. Transplant Proc 2001; 33: 11511152.
  • 13
    Behr T, Feucht H, Richter K et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 1999; 18: 904912.
  • 14
    Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 23712380.
  • 15
    Kluth-Pepper B, Schneeberger H, Lederer SR et al. Impact of humoral alloreactivity on the survival of renal allografts. Transplant Proc 1998; 30: 1778.
  • 16
    Crespo M, Pascual M, Tolkoff-Rubin N et al. Acute humoral rejection in renal allograft recipients: 1. Incidence, serology, and clinical characteristics. Transplantation 2001; 71: 652658.
  • 17
    Blanchong CA, Chung EK, Rupert KL et al. Genetic, structural and functional diversities of human complement components C4a and C4b and their mouse homologues, Slp and C4. Int Immunopharmacol 2001; 1: 365392.
  • 18
    Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Eng J Med 1986; 314: 329334.
  • 19
    Reilly BD. Analysis of human C4A and C4B binding to an immune complex in serum. Clin Exp Immunol 1999; 117: 1218.
  • 20
    Joyama S, Yoshida T, Koshikawa M et al. C4d and C4bp deposition along the glomerular capillary walls in a patient with preeclampsia. Am J Kidney Dis., 2001; 37: E6.
  • 21
    Paul LC. Immunologic risk factors for chronic renal allograft dysfunction. Transplantation 2001; 71: SS1723.
  • 22
    Doran TJ, Geczy AF, Painter D et al. A large single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation 2000; 69: 12321233.
  • 23
    McKenna RM, Takemoto SK, Terasaki PI. AntiHLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319326.
  • 24
    Gonzalez-Posada JM, Garcia-Castro MC, Tamajon LP et al. HLA-DR class II and ICAM-I expression on tubular cells taken by fine needle aspiration biopsy in renal allograft dysfunction. Nephrol Dial Transplant 1996; 11: 148152.
  • 25
    Copin MC, Noel C, Hazzan M et al. Diagnostic and predictive value of an immunohistochemical profile in asymptomatic acute rejection of renal allografts. Transpl Immunol 1995; 3: 229239.
  • 26
    Pontes LF, Carvalho L, Stumbo AC, Porto LC. Detection and localization of non-HLA-ABC antigenic sites relevant to kidney rejection on endothelial cells. J Immunol Methods 2001; 251: 7380.
  • 27
    Zhang Y, Geng H, Zhao M, Zou WEJ, Zheng X, Wang H. The significance of anti-endothelial cell antibodies in patients with lupus nephritis and immunoblotting analysis of the target components. Chin Med J 1999; 112 (7): 597602.
  • 28
    Testoni C, Borghi MO, Graham AM, Meroni PL, Lindsey N. Human monoclonal and anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro. Int Immuol 2001; 13 (3): 349357.
  • 29
    Song J, Park YB, Lee WK, Lee KH, Lee SK. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2000; 20 (1): 17.
  • 30
    Frampton G, Moriya S, Pearson JD et al. Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen. Rheumatology (Oxford) 2000; 39 (10): 11141120.
  • 31
    Praprotnik S, Revelen R, Youinou P et al. Anti-endothelial cell antibodies (AECA) in systemic sclerosis—increased sensitivity using different endothelial cell substrates and association with other autoantibodies. Autoimmunity 2001; 33 (3): 171179.
  • 32
    Igarashi A, Yazawa N, Kubo M, Kikuchi K, Takehara K, Tamaki K. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 2000; 119 (1): 203209.
  • 33
    Youinou P, Revelen R, Bordron A. Is antiendothelial cell antibody the murder weapon in systemic sclerosis? Clin Exp Rheumatol 1999; 17 (1): 5356.
  • 34
    Salojin K, Gilburg B, Shoenfeld Y, Youinou P. Anti-endothelial cell antibodies in systemic sclerosis. Clin Diagn Lab Immunol 1999; 6 (2): 156160.
  • 35
    Vazquez-Abad D, Meroni PL, Del Papa N, Falcini F, Generini S, Rothfield N, Cagnoni M. Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. Clin Exp Rheumatol 1998; 16 (5): 527532.
  • 36
    Park CW, Jin DC, Kim YS, Chang YS, Bang BK. Clinical significance of anti-endothelial cell antibody in renal transplant recipients. Korean J Intern Med 2001; 13 (5): 363371.
  • 37
    Diujvestijn AM, Derhaag JG, Van Breda Vriesman PJ. Complement activation by anti-endothelial cell antibodies in MHC-mismatched and MHC-matched heart allograft rejection: anti-MHC-, but not anti non-MHC alloantibodies are effective in complement activation. Transpl Int 2000; 13 (5): 363371.
  • 38
    Tixier D, Tuso P, Czer L et al. Characterization of antiendothelial cell and antiheart antibodies following heart transplantation. Transplant Proc 1993.